CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2, Open-label Study of Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03397394
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:07.582345+00:00
Published At: 2020-10-19T00:00:00+00:00
Record Updated At: 2023-06-09
Results Posted At: 2020-10-19
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Bladder Cancer", "Urothelial Carcinoma", "Metastatic Urothelial Carcinoma", "Renal Pelvis Carcinoma", "Ureter Carcinoma", "Urinary Bladder Carcinoma", "Urethra Carcinoma", "Muscle Invasive Bladder Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-06-09"
protocolSection.identificationModule.nctId: "NCT03397394"
protocolSection.identificationModule.officialTitle: "A Phase 2, Open-label Study of Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2020-10-19"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.